This content is machine translated Percutaneous coronary intervention How to post-treat after PCI? The type and duration of combined antithrombotic therapy vary. Decisive factors are the clinical setting (stable CHD vs. ACS), the need for additional anticoagulation (e.g., atrial fibrillation), and the patient-specific…
View Post 15 min This content is machine translated Platelet aggregation inhibition in PCI. “The flow must go on” Inhibition of coagulation is an important cornerstone of therapy for acute coronary syndrome. For this purpose, platelet aggregation inhibitors targeting thromboxane synthesis, the ADP receptor, the glycoprotein receptor IIb/IIIa and…
View Post 8 min This content is machine translated Surgical techniques and perioperative aspects Current standards of dermatosurgery Dermatosurgery deals with the surgical treatment of mainly malignant, but also benign skin neoplasms. While skin neoplasms were previously often treated by radiotherapy, cryotherapy and electrocautery, new surgical techniques and…
View Post 6 min This content is machine translated Symposium Interventional Cardiology Too much of a good thing or not enough? The Interventional Cardiology Symposium at the University Hospital Zurich was also dedicated to anticoagulants and antiplatelet agents. Here, the question was “one, two, or three?” As it turned out, the…
View Post 2 min This content is machine translated Acute coronary syndrome What medications can be used in everyday practice? In the first-line treatment of acute coronary syndrome (ACS), ticagrelor and prasugrel have been shown to be effective, according to PD Jan Steffel, MD, Zurich.
